Latest filing published 04 Mar 2015 for ARRAY BIOPHARMA INC, €81k.
Insider track record
No signal scores available.
David Snitman: trading record in brief
David Snitman discloses dealings in Array Biopharma Inc to SEC (Form 4). Over a trading history stretching from 5 December 2006 to 1 March 2015, the count stands at 14 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 4 March 2015 came the latest disclosure, an option exercise for €81k in Array Biopharma Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Snitman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,453 shares@ US$7.96Common StockSEC:0001104659-15-016809:0
- 3,976 shares@ US$7.96Common StockSEC:0001104659-15-016809:1
- 21,357 shares@ US$3.75Common StockSEC:0001127602-13-023468:0
- 15,151 shares@ US$6.07Common StockSEC:0001127602-13-023468:1
- 16,975 shares0Common StockSEC:0001127602-12-028355:0
- 37,414 shares0Common StockSEC:0001127602-11-026811:0
- 456,473 shares0Common StockSEC:0001127602-11-026811:1
- 456,473 shares0Common StockSEC:0001127602-11-026811:2
- 35,106 shares0Common StockSEC:0001127602-10-025109:0
- 33,789 shares@ US$0.60Common StockSEC:0001127602-10-019231:0
- 26,424 shares0Common StockSEC:0001127602-09-020459:0
- 33,883 shares@ US$0.235Common StockSEC:0001127602-08-011800:0
- 51,003 shares0Common StockSEC:0001100412-06-000034:0
- 8,500 shares@ US$0.235Common StockSEC:0001100412-06-000034:1
14 of 14 declarations
